$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids 원문보기

Frontiers in cell and developmental biology, v.9, 2021년, pp.748576 -   

Chang, Mingyang (Department of Clinical Pharmacy and Drug Administration, School of Pharmacy, Fudan University , Shanghai , China) ,  Bogacheva, Mariia S. (Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki , Helsinki , Finland) ,  Lou, Yan-Ru (Department of Clinical Pharmacy and Drug Administration, School of Pharmacy, Fudan University , Shanghai , China)

Abstract AI-Helper 아이콘AI-Helper

The current organoid culture systems allow pluripotent and adult stem cells to self-organize to form three-dimensional (3D) structures that provide a faithful recapitulation of the architecture and function of in vivo organs. In particular, human pluripotent stem cell-derived liver organoids (PSC-LO...

Keyword

참고문헌 (160)

  1. Ahn J. Ahn J.-H. Yoon S. Nam Y. S. Son M.-Y. Oh J.-H. ( 2019 ). Human three-dimensional in vitro model of hepatic zonation to predict zonal hepatotoxicity. J. Biol. Eng. 13 1 ? 15 . 10.1186/s13036-019-0148-5 30627214 

  2. Akbari S. Sevinc G. G. Ersoy N. Basak O. Kaplan K. Sevinc K. ( 2019 ). Robust, long-term culture of endoderm-derived hepatic organoids for disease modeling. Stem Cell Rep. 13 627 ? 641 . 10.1016/j.stemcr.2019.08.007 31522975 

  3. Amps K. Andrews P. W. Anyfantis G. Armstrong L. Avery S. Baharvand H. ( 2011 ). Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat. Biotechnol. 29 1132 ? 1144 . 10.1038/nbt.2051 22119741 

  4. Arez F. Rodrigues A. F. Brito C. Alves P. M. ( 2021 ). Bioengineered liver cell models of hepatotropic infections. Viruses 13 : 773 . 

  5. Asai A. Aihara E. Watson C. Mourya R. Mizuochi T. Shivakumar P. ( 2017 ). Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells. Development 144 1056 ? 1064 . 10.1242/dev.142794 28275009 

  6. Ashmore-Harris C. Blackford S. J. Grimsdell B. Kurtys E. Glatz M. C. Rashid T. S. ( 2019 ). Reporter gene-engineering of human induced pluripotent stem cells during differentiation renders in vivo traceable hepatocyte-like cells accessible. Stem Cell Res. 41 : 101599 . 10.1016/j.scr.2019.101599 31707210 

  7. Assou S. Girault N. Plinet M. Bouckenheimer J. Sansac C. Combe M. ( 2020 ). Recurrent genetic abnormalities in human pluripotent stem cells: definition and routine detection in culture supernatant by targeted droplet digital PCR. Stem Cell Rep. 14 1 ? 8 . 10.1016/j.stemcr.2019.12.004 31902703 

  8. Baptista P. M. Siddiqui M. M. Lozier G. Rodriguez S. R. Atala A. Soker S. ( 2011 ). The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology 53 604 ? 617 . 21274881 

  9. Baxter M. Withey S. Harrison S. Segeritz C.-P. Zhang F. Atkinson-Dell R. ( 2015 ). Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes. J. Hepatol. 62 581 ? 589 . 10.1016/j.jhep.2014.10.016 25457200 

  10. Bhutani K. Nazor K. L. Williams R. Tran H. Dai H. Dakula , et al. ( 2016 ). Whole-genome mutational burden analysis of three pluripotency induction methods. Nat. Commun. 7 : 10536 . 10.1038/ncomms10536 26892726 

  11. Boulting G. L. Kiskinis E. Croft G. F. Amoroso M. W. Oakley D. H. Wainger B. J. ( 2011 ). A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29 279 ? 286 . 21293464 

  12. Brooks A. Liang X. Zhang Y. Zhao C. X. Roberts M. S. Wang H. ( 2021 ). Liver organoid as a 3D in vitro model for drug validation and toxicity assessment. Pharmacol. Res. 169 105608 . 10.1016/j.phrs.2021.105608 33852961 

  13. Broutier L. Mastrogiovanni G. Verstegen M. M. A. Francies H. E. Gavarro L. M. Bradshaw C. R. ( 2017 ). Human primary liver cancer?derived organoid cultures for disease modeling and drug screening. Nat. Med. 23 1424 ? 1435 . 10.1038/nm.4438 29131160 

  14. Bulutoglu B. Rey-Bedon C. Kang Y. B. A. Mert S. Yarmush M. L. Usta O. B. ( 2019 ). A microfluidic patterned model of non-alcoholic fatty liver disease: applications to disease progression and zonation. Lab Chip 19 3022 ? 3031 . 10.1039/c9lc00354a 31465069 

  15. Burdick J. A. Prestwich G. D. ( 2011 ). Hyaluronic acid hydrogels for biomedical applications. Adv. Mater. 23 H41 ? H56 . 21394792 

  16. Burrows C. K. Banovich N. E. Pavlovic B. J. Patterson K. Gallego Romero I. Pritchard J. K. ( 2016 ). Genetic variation, not cell type of origin, underlies the majority of identifiable regulatory differences in iPSCs. PLoS Genet. 12 : e1005793 . 10.1371/journal.pgen.1005793 26812582 

  17. Cahan P. Daley G. Q. ( 2013 ). Origins and implications of pluripotent stem cell variability and heterogeneity. Nat. Rev. Mol. Cell Biol. 14 357 ? 368 . 23673969 

  18. Collins S. D. Yuen G. Tu T. Budzinska M. A. Spring K. Bryant K. ( 2019 ). “In vitro models of the liver: disease modeling, drug discovery and clinical applications,” in Hepatocellular Carcinoma , ed. Tirnitz-Parker J. E. E. ( Brisbane, QLD : Codon Publications ). 

  19. D’Antonio M. Benaglio P. Jakubosky D. Greenwald W. W. Matsui H. Donovan M. K. ( 2018 ). Insights into the mutational burden of human induced pluripotent stem cells from an integrative multi-omics approach. Cell Rep. 24 883 ? 894 . 10.1016/j.celrep.2018.06.091 30044985 

  20. Davidson M. D. Khetani S. R. ( 2020 ). Intermittent starvation extends the functional lifetime of primary human hepatocyte cultures. Toxicol. Sci. 174 266 ? 277 . 10.1093/toxsci/kfaa003 31977024 

  21. Deegan D. B. Zimmerman C. Skardal A. Atala A. Shupe T. D. ( 2016 ). Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology. J. Mech. Behav. Biomed. Mater. 55 87 ? 103 . 10.1016/j.jmbbm.2015.10.016 26569044 

  22. Du C. Narayanan K. Leong M. F. Wan A. C. ( 2014 ). Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering. Biomaterials 35 6006 ? 6014 . 10.1016/j.biomaterials.2014.04.011 24780169 

  23. Faulkner-Jones A. Fyfe C. Cornelissen D.-J. Gardner J. King J. Courtney A. ( 2015 ). Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D. Biofabrication 7 : 044102 . 10.1088/1758-5090/7/4/044102 

  24. Fedorovich N. E. Alblas J. de Wijn J. R. Hennink W. E. Verbout A. J. Dhert W. J. ( 2007 ). Hydrogels as extracellular matrices for skeletal tissue engineering: state-of-the-art and novel application in organ printing. Tissue Eng. 13 1905 ? 1925 . 10.1089/ten.2006.0175 17518748 

  25. Fu Y. Foden J. A. Khayter C. Maeder M. L. Reyon D. Joung J. K. ( 2013 ). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31 822 ? 826 . 23792628 

  26. Galle P. R. Hagelstein J. Kommerell B. Volkmann M. Schranz P. Zentgraf H. ( 1994 ). In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106 664 ? 673 . 8119538 

  27. Ganesh K. Wu C. O’Rourke K. P. Szeglin B. C. Zheng Y. Sauve C. G. ( 2019 ). A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25 1607 ? 1614 . 10.1038/s41591-019-0584-2 31591597 

  28. Gieseck R. L. III Hannan N. R. Bort R. Hanley N. A. Drake R. A. Cameron G. W. ( 2014 ). Maturation of induced pluripotent stem cell derived hepatocytes by 3D-culture. PLoS One 9 : e86372 . 10.1371/journal.pone.0086372 24466060 

  29. Giobbe G. G. Crowley C. Luni C. Campinoti S. Khedr M. Kretzschmar K. ( 2019 ). Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture. Nat. Commun. 10 1 ? 14 . 10.1038/s41467-019-13605-4 30602773 

  30. Goulart E. de Caires-Junior L. C. Telles-Silva K. A. Araujo B. H. S. Kobayashi G. S. Musso C. M. ( 2019 ). Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-β. Stem Cell. Res. Ther. 10 1 ? 11 . 10.1186/s13287-019-1367-x 30606242 

  31. Grskovic M. Javaherian A. Strulovici B. Daley G. Q. ( 2011 ). Induced pluripotent stem cells―opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 10 915 ? 929 . 10.1038/nrd3577 22076509 

  32. Guan Y. Xu D. Garfin P. M. Ehmer U. Hurwitz M. Enns G. ( 2017 ). Human hepatic organoids for the analysis of human genetic diseases. JCI Insight 2 : e94954 . 

  33. Gupta S. Rajvanshi P. Sokhi R. Slehria S. Yam A. Kerr A. ( 1999 ). Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29 509 ? 519 . 10.1002/hep.510290213 9918929 

  34. Gural N. Mancio-Silva L. He J. Bhatia S. N. ( 2018 ). Engineered livers for infectious diseases. Cell. Mol. Gastroenterol. Hepatol. 5 131 ? 144 . 29322086 

  35. Hall Z. Bond N. J. Ashmore T. Sanders F. Ament Z. Wang X. ( 2017 ). Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease. Hepatology 65 1165 ? 1180 . 10.1002/hep.28953 27863448 

  36. Hendriks D. Artegiani B. Hu H. de Sousa Lopes S. C. Clevers H. ( 2021 ). Establishment of human fetal hepatocyte organoids and CRISPR-Cas9-based gene knockin and knockout in organoid cultures from human liver. Nat. Protoc. 16 182 ? 217 . 10.1038/s41596-020-00411-2 33247284 

  37. Hong C.-H. Sohn H.-J. Lee H.-J. Cho H.-I. Kim T.-G. ( 2017 ). Antigen presentation by individually transferred HLA class i genes in HLA-A, HLA-B, HLA-C null human cell line generated using the multiplex CRISPR-Cas9 system. J. Immunother. 40 201 ? 210 . 10.1097/CJI.0000000000000176 28604557 

  38. Hou Z. Zhang Y. Propson N. E. Howden S. E. Chu L.-F. Sontheimer E. J. ( 2013 ). Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis . Proc. Natl. Acad. Sci. U.S.A. 110 15644 ? 15649 . 10.1073/pnas.1313587110 23940360 

  39. Hsia G. S. P. Esposito J. da Rocha L. A. Ramos S. L. G. Okamoto O. K. ( 2021 ). Clinical application of human induced pluripotent stem cell-derived organoids as an alternative to organ transplantation. Stem Cells Int. 2021 6632160 . 10.1155/2021/6632160 33679987 

  40. Hu H. Gehart H. Artegiani B. LOpez-Iglesias C. Dekkers F. Basak O. ( 2018 ). Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175 1591 ? 1606.e1519 . 30500538 

  41. Huang S. ( 2009 ). Non-genetic heterogeneity of cells in development: more than just noise. Development 136 3853 ? 3862 . 19906852 

  42. Huch M. Gehart H. Van Boxtel R. Hamer K. Blokzijl F. Verstegen M. M. ( 2015 ). Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160 299 ? 312 . 10.1016/j.cell.2014.11.050 25533785 

  43. Inoue H. Yamanaka S. ( 2011 ). The use of induced pluripotent stem cells in drug development. Clin. Pharmacol. Ther. 89 655 ? 661 . 21430656 

  44. Janani G. Mandal B. B. ( 2021 ). Mimicking physiologically relevant hepatocyte zonation using immunomodulatory silk liver extracellular matrix scaffolds toward a bioartificial liver platform. ACS Appl. Mater. Interfaces 13 , 24401 ? 24421 . 10.1021/acsami.1c00719 34019382 

  45. Ji J. Ng S. H. Sharma V. Neculai D. Hussein S. Sam M. ( 2012 ). Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells 30 435 ? 440 . 10.1002/stem.1011 22162363 

  46. Jung K. B. Lee H. Son Y. S. Lee M.-O. Kim Y.-D. Oh S. J. ( 2018 ). Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids. Nat. Commun. 9 : 3039 . 10.1038/s41467-018-05450-8 30072687 

  47. Kietzmann T. ( 2017 ). Metabolic zonation of the liver: the oxygen gradient revisited. Redox Biol. 11 622 ? 630 . 10.1016/j.redox.2017.01.012 28126520 

  48. Kilpinen H. Goncalves A. Leha A. Afzal V. Alasoo K. Ashford S. ( 2017 ). Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546 370 ? 375 . 28489815 

  49. Kim K. Zhao R. Doi A. Ng K. Unternaehrer J. Cahan P. ( 2011 ). Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat. Biotechnol. 29 1117 ? 1119 . 22119740 

  50. Kleinstiver B. P. Pattanayak V. Prew M. S. Tsai S. Q. Nguyen N. T. Zheng Z. ( 2016 ). High-fidelity CRISPR?Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529 490 ? 495 . 10.1038/nature16526 26735016 

  51. Klotz B. J. Oosterhoff L. A. Utomo L. Lim K. S. Vallmajo-Martin Q. Clevers H. ( 2019 ). A versatile biosynthetic hydrogel platform for engineering of tissue analogues. Adv. Healthcare Mater. 8 : e1900979 . 10.1002/adhm.201900979 31402634 

  52. Koepsell H. Lips K. Volk C. ( 2007 ). Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 24 1227 ? 1251 . 10.1007/s11095-007-9254-z 17473959 

  53. Kruger M. Oosterhoff L. A. van Wolferen M. E. Schiele S. A. Walther A. Geijsen N. ( 2020 ). Cellulose nanofibril hydrogel promotes hepatic differentiation of human liver organoids. Adv. Healthcare Mater. 9 : e1901658 . 10.1002/adhm.201901658 32090504 

  54. Kryou C. Leva V. Chatzipetrou M. Zergioti I. ( 2019 ). Bioprinting for liver transplantation. Bioengineering 6 : 95 . 10.3390/bioengineering6040095 31658719 

  55. Kuijk E. Jager M. van der Roest B. Locati M. D. Van Hoeck A. Korzelius J. ( 2020 ). The mutational impact of culturing human pluripotent and adult stem cells. Nat. Commun. 11 : 2493 . 

  56. Kuo C. J. Curtis C. ( 2018 ). Organoids Reveal Cancer Dynamics. Berlin : Nature Publishing Group . 

  57. Lancaster M. A. Renner M. Martin C.-A. Wenzel D. Bicknell L. S. Hurles M. E. ( 2013 ). Cerebral organoids model human brain development and microcephaly. Nature 501 373 ? 379 . 23995685 

  58. Laurent L. C. Ulitsky I. Slavin I. Tran H. Schork A. Morey R. ( 2011 ). Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8 106 ? 118 . 10.1016/j.stem.2010.12.003 21211785 

  59. Lee G. Kim H. Park J. Y. Kim G. Han J. Chung S. ( 2021 ). Generation of uniform liver spheroids from human pluripotent stem cells for imaging-based drug toxicity analysis. Biomaterials 269 120529 . 10.1016/j.biomaterials.2020.120529 33257114 

  60. Lee J. Sheen J. H. Lim O. Lee Y. Ryu J. Shin D. ( 2020 ). Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy. Sci. Rep. 10 1 ? 10 . 10.1038/s41598-020-74772-9 31913322 

  61. Leung A. W. Broton C. Bogacheva M. S. Xiao A. Z. Garcia-Castro M. I. Lou Y.-R. ( 2020 ). RNA-based CRISPR-mediated loss-of-function mutagenesis in human pluripotent stem cells. J. Mol. Biol. 432 3956 ? 3964 . 10.1016/j.jmb.2020.04.017 32339532 

  62. Liang G. Zhang Y. ( 2013 ). Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13 149 ? 159 . 23910082 

  63. Lin X. Tang J. Lou Y.-R. ( 2021 ). Human pluripotent stem-cell-derived models as a missing link in drug discovery and development. Pharmaceuticals 14 : 525 . 10.3390/ph14060525 34070895 

  64. Lou Y.-R. Leung A. W. ( 2018 ). Next generation organoids for biomedical research and applications. Biotechnol. Adv. 36 132 ? 149 . 29056474 

  65. Lou Y.-R. Kanninen L. Kuisma T. Niklander J. Noon L. A. Burks D. ( 2014 ). The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells. Stem Cells Dev. 23 380 ? 392 . 10.1089/scd.2013.0314 24188453 

  66. Lucendo-Villarin B. Meseguer-Ripolles J. Drew J. Fischer L. Ma E. Flint O. ( 2020 ). Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research. Biofabrication 13 : 015009 . 10.1088/1758-5090/abbdb2 33007774 

  67. Lynch S. Pridgeon C. S. Duckworth C. A. Sharma P. Park B. K. Goldring C. E. P. ( 2019 ). Stem cell models as an in vitro model for predictive toxicology. Biochem. J. 476 1149 ? 1158 . 10.1042/BCJ20170780 30988136 

  68. Mandai M. Watanabe A. Kurimoto Y. Hirami Y. Morinaga C. Daimon T. ( 2017 ). Autologous induced stem-cell?derived retinal cells for macular degeneration. N. Engl. J. Med. 376 1038 ? 1046 . 28296613 

  69. Manou D. Caon I. Bouris P. Triantaphyllidou I.-E. Giaroni C. Passi A. ( 2019 ). The complex interplay between extracellular matrix and cells in tissues. Extracell. Matrix 1952 1 ? 20 . 

  70. Mansour A. A. Goncalves J. T. Bloyd C. W. Li H. Fernandes S. Quang D. ( 2018 ). An in vivo model of functional and vascularized human brain organoids. Nat. Biotechnol. 36 432 ? 441 . 29658944 

  71. Martins-Taylor K. Nisler B. S. Taapken S. M. Compton T. Crandall L. Montgomery K. D. ( 2011 ). Recurrent copy number variations in human induced pluripotent stem cells. Nat. Biotechnol. 29 488 ? 491 . 21654665 

  72. Mayshar Y. Ben-David U. Lavon N. Biancotti J.-C. Yakir B. Clark A. T. ( 2010 ). Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7 521 ? 531 . 10.1016/j.stem.2010.07.017 20887957 

  73. Mekhoubad S. Bock C. De Boer A. S. Kiskinis E. Meissner A. Eggan K. ( 2012 ). Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10 595 ? 609 . 22560080 

  74. Miller A. J. Dye B. R. Ferrer-Torres D. Hill D. R. Overeem A. W. Shea L. D. ( 2019 ). Generation of lung organoids from human pluripotent stem cells in vitro. Nat. Protoc. 14 518 ? 540 . 30664680 

  75. Minami T. Ishii T. Yasuchika K. Fukumitsu K. Ogiso S. Miyauchi Y. ( 2019 ). Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold. Regen. Ther. 10 127 ? 133 . 10.1016/j.reth.2019.03.002 31032388 

  76. Mun S. J. Hong Y.-H. Ahn H.-S. Ryu J.-S. Chung K.-S. Son M. J. ( 2020 ). Long-term expansion of functional human pluripotent stem cell-derived hepatic organoids. Int. J. Stem Cells 13 : 279 . 

  77. Mun S. J. Lee J. Chung K. S. Son M. Y. Son M. J. ( 2021 ). Effect of microbial short-chain fatty acids on CYP3A4-mediated metabolic activation of human pluripotent stem cell-derived liver organoids. Cells 10 : 126 . 10.3390/cells10010126 33440728 

  78. Muthuswamy S. K. ( 2018 ). Organoid models of cancer explode with possibilities. Cell Stem Cell 22 290 ? 291 . 10.1016/j.stem.2018.02.010 29499146 

  79. Nagamoto Y. Takayama K. Ohashi K. Okamoto R. Sakurai F. Tachibana M. ( 2016 ). Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. J. Hepatol. 64 1068 ? 1075 . 10.1016/j.jhep.2016.01.004 26778754 

  80. National Center For Health Statistics ( 2021 ). Health, United States, 2019. Hyattsville, MD : National Center For Health Statistics . 

  81. Ng S. S. Saeb-Parsy K. Blackford S. J. I. Segal J. M. Serra M. P. Horcas-Lopez M. ( 2018 ). Human iPS derived progenitors bioengineered into liver organoids using an inverted colloidal crystal poly (ethylene glycol) scaffold. Biomaterials 182 299 ? 311 . 10.1016/j.biomaterials.2018.07.043 30149262 

  82. Ng S. Schwartz R. E. March S. Galstian A. Gural N. Shan J. ( 2015 ). Human iPSC-derived hepatocyte-like cells support Plasmodium liver-stage infection in vitro. Stem Cell Rep. 4 348 ? 359 . 10.1016/j.stemcr.2015.01.002 25660406 

  83. Nie Y.-Z. Zheng Y.-W. Miyakawa K. Murata S. Zhang R.-R. Sekine K. ( 2018 ). Recapitulation of hepatitis B virus?host interactions in liver organoids from human induced pluripotent stem cells. EBioMedicine 35 114 ? 123 . 30120080 

  84. Nishizawa M. Chonabayashi K. Nomura M. Tanaka A. Nakamura M. Inagaki A. ( 2016 ). Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity. Cell Stem Cell 19 341 ? 354 . 10.1016/j.stem.2016.06.019 27476965 

  85. Nunez J. K. Harrington L. B. Doudna J. A. ( 2016 ). Chemical and biophysical modulation of Cas9 for tunable genome engineering. ACS Chem. Biol. 11 681 ? 688 . 10.1021/acschembio.5b01019 26857072 

  86. Oberwallner B. Brodarac A. Choi Y. H. Saric T. Ani P. Morawietz L. ( 2014 ). Preparation of cardiac extracellular matrix scaffolds by decellularization of human myocardium. J. Biomed. Mater. Res. Part A 102 3263 ? 3272 . 

  87. Ogawa S. Surapisitchat J. Virtanen C. Niapour M. Sugamori K. S. Wang S. ( 2013 ). Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development 140 3285 ? 3296 . 10.1242/dev.090266 23861064 

  88. Ogoke O. Maloy M. Parashurama N. ( 2021 ). The science and engineering of stem cell-derived organoids-examples from hepatic, biliary, and pancreatic tissues. Biol. Rev. Camb. Philos. Soc. 96 179 ? 204 . 10.1111/brv.12650 33002311 

  89. Okita K. Matsumura Y. Sato Y. Okada A. Morizane A. Okamoto S. ( 2011 ). A more efficient method to generate integration-free human iPS cells. Nat. Methods 8 409 ? 412 . 21460823 

  90. Orkin R. Gehron P. Mcgoodwin E. B. Martin G. Valentine T. Swarm R. ( 1977 ). A murine tumor producing a matrix of basement membrane. J. Exp. Med. 145 204 ? 220 . 830788 

  91. Ott H. C. Matthiesen T. S. Goh S.-K. Black L. D. Kren S. M. Netoff T. I. ( 2008 ). Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med. 14 213 ? 221 . 10.1038/nm1684 18193059 

  92. Ouchi R. Togo S. Kimura M. Shinozawa T. Koido M. Koike H. ( 2019 ). Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab. 30 374 ? 384.e376 . 31155493 

  93. Papapetrou E. P. ( 2016 ). Patient-derived induced pluripotent stem cells in cancer research and precision oncology. Nat. Med. 22 1392 ? 1401 . 27923030 

  94. Pauli C. Hopkins B. D. Prandi D. Shaw R. Fedrizzi T. Sboner A. ( 2017 ). Personalized in vitro and in vivo cancer models to guide precision medicine. Cancer Discov. 7 462 ? 477 . 28331002 

  95. Peng W. C. Logan C. Y. Fish M. Anbarchian T. Aguisanda F. Alvarez-Varela A. ( 2018 ). Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture. Cell 175 1607 ? 1619. e1615 10.1016/j.cell.2018.11.012 30500539 

  96. Pettinato G. Lehoux S. Ramanathan R. Salem M. M. He L.-X. Muse O. ( 2019 ). Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with endothelial cells. Sci. Rep. 9 1 ? 21 . 10.1038/s41598-019-45514-3 30626917 

  97. Planas-Paz L. Orsini V. Boulter L. Calabrese D. Pikiolek M. Nigsch F. ( 2016 ). The RSPO?LGR4/5?ZNRF3/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18 467 ? 479 . 27088858 

  98. Plummer S. Wallace S. Ball G. Lloyd R. Schiapparelli P. Quinones-Hinojosa A. ( 2019 ). A human iPSC-derived 3D platform using primary brain cancer cells to study drug development and personalized medicine. Sci. Rep. 9 1 ? 11 . 10.1038/s41598-018-38130-0 30626917 

  99. Polo J. M. Liu S. Figueroa M. E. Kulalert W. Eminli S. Tan K. Y. ( 2010 ). Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28 848 ? 855 . 10.1038/nbt.1667 20644536 

  100. Pope I. Masia F. Ewan K. Jimenez-Pascual A. Dale T. C. Siebzehnrubl F. A. ( 2021 ). Identifying subpopulations in multicellular systems by quantitative chemical imaging using label-free hyperspectral CARS microscopy. Analyst 146 2277 ? 2291 . 10.1039/d0an02381g 33617612 

  101. Popper H. Schaffner F. ( 1957 ). Liver: Structure And Function. New York, NY : McGraw Hill . 

  102. Prodanov L. Jindal R. Bale S. S. Hegde M. McCarty W. J. Golberg I. ( 2016 ). Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol. Bioeng. 113 241 ? 246 . 10.1002/bit.25700 26152452 

  103. Raju R. Chau D. Cho D. S. Park Y. Verfaillie C. M. Hu W.-S. ( 2017 ). Cell expansion during directed differentiation of stem cells toward the hepatic lineage. Stem Cells Dev. 26 274 ? 284 . 27806669 

  104. Ramli M. N. B. Lim Y. S. Koe C. T. Demircioglu D. Tng W. Gonzales K. A. U. ( 2020 ). Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology 159 1471 ? 1486 e1412 . 10.1053/j.gastro.2020.06.010 32553762 

  105. Ran F. A. Cong L. Yan W. X. Scott D. A. Gootenberg J. S. Kriz A. J. ( 2015 ). In vivo genome editing using Staphylococcus aureus Case. Nature 520 186 ? 191 . 25830891 

  106. Rashidi H. Luu N. T. Alwahsh S. M. Ginai M. Alhaque S. Dong H. ( 2018 ). 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo. Arch. Toxicol. 92 3117 ? 3129 . 10.1007/s00204-018-2280-2 30155720 

  107. Reintjes J. Duncan M. D. Manuccia T. J. ( 1982 ). “Picosecond coherent anti-stokes raman scattering (CARS) Microscope,” in Proceedings of the SPIE 0322, Picosecond Lasers and Applications , Los Angeles, CA . 

  108. Roelandt P. Obeid S. Paeshuyse J. Vanhove J. Van Lommel A. Nahmias Y. ( 2012 ). Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J. Hepatol. 57 246 ? 251 . 10.1016/j.jhep.2012.03.030 22521345 

  109. Rossi G. Broguiere N. Miyamoto M. Boni A. Guiet R. Girgin M. ( 2021 ). Capturing cardiogenesis in gastruloids. Cell Stem Cell 28 230 ? 240. e236 . 10.1016/j.stem.2020.10.013 33176168 

  110. Schene I. F. Joore I. P. Oka R. Mokry M. van Vugt A. H. M. van Boxtel R. ( 2020 ). Prime editing for functional repair in patient-derived disease models. Nat. Commun. 11 : 5352 . 10.1038/s41467-020-19136-7 33097693 

  111. Schneeberger K. Sanchez-Romero N. Ye S. van Steenbeek F. G. Oosterhoff L. A. Pla Palacin I. ( 2020 ). Large-scale production of LGR5-positive bipotential human liver stem cells. Hepatology 72 257 ? 270 . 10.1002/hep.31037 31715015 

  112. Schulze A. Mills K. Weiss T. S. Urban S. ( 2012 ). Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 55 373 ? 383 . 10.1002/hep.24707 21953491 

  113. Schwartz R. E. Trehan K. Andrus L. Sheahan T. P. Ploss A. Duncan S. A. ( 2012 ). Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc. Natl. Acad. Sci. U.S.A. 109 2544 ? 2548 . 22308485 

  114. Schwarz S. Koerber L. Elsaesser A. F. Goldberg-Bockhorn E. Seitz A. M. Durselen L. ( 2012 ). Decellularized cartilage matrix as a novel biomatrix for cartilage tissue-engineering applications. Tissue Eng. Part A 18 2195 ? 2209 . 10.1089/ten.TEA.2011.0705 22690787 

  115. Serra D. Mayr U. Boni A. Lukonin I. Rempfler M. Meylan L. C. ( 2019 ). Self-organization and symmetry breaking in intestinal organoid development. Nature 569 66 ? 72 . 10.1038/s41586-019-1146-y 31019299 

  116. Sgodda M. Dai Z. Zweigerdt R. Sharma A. D. Ott M. Cantz T. ( 2017 ). A scalable approach for the generation of human pluripotent stem cell-derived hepatic organoids with sensitive hepatotoxicity features. Stem Cells Dev. 26 1490 ? 1504 . 10.1089/scd.2017.0023 28699415 

  117. Sharma S. Raju R. Sui S. Hu W. S. ( 2011 ). Stem cell culture engineering?process scale up and beyond. Biotechnol. J. 6 1317 ? 1329 . 10.1002/biot.201000435 21721127 

  118. Shlomai A. Schwartz R. E. Ramanan V. Bhatta A. de Jong Y. P. Bhatia S. N. ( 2014 ). Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems. Proc. Natl. Acad. Sci. U.S.A. 111 12193 ? 12198 . 10.1073/pnas.1412631111 25092305 

  119. Si-Tayeb K. Lemaigre F. P. Duncan S. A. ( 2010 ). Organogenesis and development of the liver. Dev. Cell 18 175 ? 189 . 20159590 

  120. Song W. Lu Y.-C. Frankel A. S. An D. Schwartz R. E. Ma M. ( 2015 ). Engraftment of human induced pluripotent stem cell-derived hepatocytes in immunocompetent mice via 3D co-aggregation and encapsulation. Sci. Rep. 5 1 ? 13 . 10.1038/srep16884 26592180 

  121. Sorrentino G. Rezakhani S. Yildiz E. Nuciforo S. Heim M. H. Lutolf M. P. ( 2020 ). Mechano-modulatory synthetic niches for liver organoid derivation. Nat. Commun. 11 1 ? 10 . 10.1038/s41467-020-17161-0 31911652 

  122. Stieger B. ( 2011 ). The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Drug Transporters 201 205 ? 259 . 

  123. Sugimoto S. Sato T. ( 2017 ). “Establishment of 3D intestinal organoid cultures from intestinal stem cells,” in 3D Cell Culture. Methods in Molecular Biology , ed. Koledova Z. ( Berlin : Springer ), 97 ? 105 . 

  124. Szot G. L. Yadav M. Lang J. Kroon E. Kerr J. Kadoya K. ( 2015 ). Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm. Cell Stem Cell 16 148 ? 157 . 10.1016/j.stem.2014.12.001 25533131 

  125. Takahashi K. Tanabe K. Ohnuki M. Narita M. Ichisaka T. Tomoda K. ( 2007 ). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 861 ? 872 . 18035408 

  126. Takasato M. Pei X. E. Chiu H. S. Maier B. Baillie G. J. Ferguson C. ( 2015 ). Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526 564 ? 568 . 26444236 

  127. Takebe T. Sekine K. Enomura M. Koike H. Kimura M. Ogaeri T. ( 2013 ). Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499 481 ? 484 . 10.1038/nature12271 23823721 

  128. Takebe T. Sekine K. Kimura M. Yoshizawa E. Ayano S. Koido M. ( 2017 ). Massive and reproducible production of liver buds entirely from human pluripotent stem cells. Cell Rep. 21 2661 ? 2670 . 10.1016/j.celrep.2017.11.005 29212014 

  129. Tam P. P. L. Loebel D. A. F. ( 2007 ). Gene function in mouse embryogenesis: get set for gastrulation. Nat. Rev. Genet. 8 368 ? 381 . 10.1038/nrg2084 17387317 

  130. Taylor C. J. Peacock S. Chaudhry A. N. Bradley J. A. Bolton E. M. ( 2012 ). Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 11 147 ? 152 . 10.1016/j.stem.2012.07.014 22862941 

  131. Thompson W. L. Takebe T. ( 2021 ). Human liver model systems in a dish. Dev. Growth Differ. 63 47 ? 58 . 10.1111/dgd.12708 33423319 

  132. Touboul T. Hannan N. R. F. Corbineau S. Martinez A. Martinet C. Branchereau S. ( 2010 ). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51 1754 ? 1765 . 10.1002/hep.23506 20301097 

  133. Tsuchida T. Murata S. Hasegawa S. Mikami S. Enosawa S. Hsu H.-C. ( 2020 ). Investigation of clinical safety of human iPS cell-derived liver organoid transplantation to infantile patients in porcine model. Cell Transplant 29 : 0963689720964384 . 10.1177/0963689720964384 33103476 

  134. Tsuchida T. Murata S. Matsuki K. Mori A. Matsuo M. Mikami S. ( 2019 ). The Regenerative effect of portal vein injection of liver organoids by retrorsine/partial hepatectomy in rats. Int. J. Mol. Sci. 21 : 178 . 10.3390/ijms21010178 31887985 

  135. Tsuji O. Miura K. Okada Y. Fujiyoshi K. Mukaino M. Nagoshi N. ( 2010 ). Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 107 12704 ? 12709 . 10.1073/pnas.0910106107 20615974 

  136. Uygun B. E. Soto-Gutierrez A. Yagi H. Izamis M.-L. Guzzardi M. A. Shulman C. ( 2010 ). Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 16 : 814 . 

  137. Valamehr B. Robinson M. Abujarour R. Rezner B. Vranceanu F. Le T. ( 2014 ). Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep. 2 366 ? 381 . 10.1016/j.stemcr.2014.01.014 24672758 

  138. van Ineveld R. L. Ariese H. C. R. Wehrens E. J. Dekkers J. F. Rios A. C. ( 2020 ). Single-cell resolution three-dimensional imaging of intact organoids. J. Vis. Exp. 10.3791/60709 32568249 

  139. Vassena R. Montserrat N. Carrasco Canal B. Aran B. de Onate L. Veiga A. ( 2012 ). Accumulation of instability in serial differentiation and reprogramming of parthenogenetic human cells. Hum. Mol. Genet. 21 3366 ? 3373 . 10.1093/hmg/dds168 22547223 

  140. Vlachogiannis G. Hedayat S. Vatsiou A. Jamin Y. Fernandez-Mateos J. Khan K. ( 2018 ). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359 920 ? 926 . 29472484 

  141. Wang B. Jakus A. E. Baptista P. M. Soker S. Soto-Gutierrez A. Abecassis M. M. ( 2016 ). Functional maturation of induced pluripotent stem cell hepatocytes in extracellular matrix―a comparative analysis of bioartificial liver microenvironments. Stem Cells Transl. Med. 5 1257 ? 1267 . 10.5966/sctm.2015-0235 27421950 

  142. Wang H. Calvisi D. F. Chen X. ( 2021 ). Organoids for the study of liver cancer. Semin. Liver Dis. 41 19 ? 27 . 10.1055/s-0040-1719176 33764482 

  143. Wang K. Guzman A. K. Yan Z. Zhang S. Hu M. Y. Hamaneh M. B. ( 2019 ). Ultra-high-frequency reprogramming of individual long-term hematopoietic stem cells yields low somatic variant induced pluripotent stem cells. Cell Rep. 26 2580 ? 2592. E2587 . 10.1016/j.celrep.2019.02.021 30840883 

  144. Wang S. Wang X. Tan Z. Su Y. Liu J. Chang M. ( 2019 ). Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury. Cell Res. 29 1009 ? 1026 . 10.1038/s41422-019-0242-8 31628434 

  145. Wang Y. Cui C. B. Yamauchi M. Miguez P. Roach M. Malavarca R. ( 2011 ). Lineage restriction of human hepatic stem cells to mature fates is made efficient by tissue-specific biomatrix scaffolds. Hepatology 53 293 ? 305 . 10.1002/hep.24012 21254177 

  146. Watson C. L. Mahe M. M. Munera J. Howell J. C. Sundaram N. Poling H. M. ( 2014 ). An in vivo model of human small intestine using pluripotent stem cells. Nat. Med. 20 1310 ? 1314 . 10.1038/nm.3737 25326803 

  147. Weiss M. J. Ray K. Henthorn P. S. Lamb B. Kadesch T. Harris H. ( 1988 ). Structure of the human liver/bone/kidney alkaline phosphatase gene. J. Biol. Chem. 263 12002 ? 12010 . 3165380 

  148. Worsdorfer P. I. T. Asahina I. Sumita Y. Ergun S. ( 2020 ). Do not keep it simple: recent advances in the generation of complex organoids. J. Neural Transm. (Vienna) 127 1569 ? 1577 . 10.1007/s00702-020-02198-8 32385575 

  149. Wu F. Wu D. Ren Y. Huang Y. Feng B. Zhao N. ( 2019 ). Generation of hepatobiliary organoids from human induced pluripotent stem cells. J. Hepatol. 70 1145 ? 1158 . 30630011 

  150. Wu X. Robotham J. M. Lee E. Dalton S. Kneteman N. M. Gilbert D. M. ( 2012 ). Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 8 : e1002617 . 10.1371/journal.ppat.1002617 22496645 

  151. Xu H. Wang B. Ono M. Kagita A. Fujii K. Sasakawa N. ( 2019 ). Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell 24 566 ? 578 e567 . 10.1016/j.stem.2019.02.005 30853558 

  152. Xu J. Zeger S. L. ( 2001 ). The evaluation of multiple surrogate endpoints. Biometrics 57 81 ? 87 . 11252622 

  153. Yan H. Zhong G. Xu G. He W. Jing Z. Gao Z. ( 2012 ). Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. elife 1 : e00049 . 

  154. Ye S. Boeter J. W. Mihajlovic M. van Steenbeek F. G. van Wolferen M. E. Oosterhoff L. A. ( 2020 ). A chemically defined hydrogel for human liver organoid culture. Adv. Funct. Mater. 30 : 2000893 . 

  155. Yin X. Mead B. E. Safaee H. Langer R. Karp J. M. Levy O. ( 2016 ). Engineering stem cell organoids. Cell Stem Cell 18 25 ? 38 . 10.1016/j.stem.2015.12.005 26748754 

  156. Yu J. Vodyanik M. A. Smuga-Otto K. Antosiewicz-Bourget J. Frane J. L. Tian S. ( 2007 ). Induced pluripotent stem cell lines derived from human somatic cells. Science 318 1917 ? 1920 . 18029452 

  157. Zahmatkesh E. Ghanian M. H. Zarkesh I. Farzaneh Z. Halvaei M. Heydari Z. ( 2021 ). Tissue-specific microparticles improve organoid microenvironment for efficient maturation of pluripotent stem-cell-derived hepatocytes. Cells 10 : 1274 . 10.3390/cells10061274 34063948 

  158. Zhang M. Sun P. Wang Y. Chen J. Lv L. Wei W. ( 2015 ). Generation of self-renewing hepatoblasts from human embryonic stem cells by chemical approaches. Stem Cells Transl. Med. 4 1275 ? 1282 . 10.5966/sctm.2015-0051 26371343 

  159. Zhao T. Zhang Z.-N. Westenskow P. D. Todorova D. Hu Z. Lin T. ( 2015 ). Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells. Cell Stem Cell 17 353 ? 359 . 10.1016/j.stem.2015.07.021 26299572 

  160. Zhu M. Huang Y. Bian S. Song Q. Zhang J. Zheng W. ( 2020 ). Organoid: current implications and pharmaceutical applications in liver diseases. Curr. Mol. Pharmacol. 10.2174/1874467213666201217115854 33334301 

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 논문

해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로